Results 301 to 310 of about 1,678,607 (395)

The Neuropsychological Dimensions to Pathogenesis of Chronic Spontaneous Urticaria Beyond Autoallergy - A Brief Narrative Review. [PDF]

Indian Dermatol Online J
Kumaran MS, Kaur S, Parsad D, Narang T.
europepmc   +1 more source

Production of human growth hormone antagonist (hGHG120R) in Chinese hamster ovary cells

, 1997
Raj Haldankar
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hormones and hormone antagonists

2015
Gerard H.A. Visser, Corinna Weber-Schöndorfer   +1 more
openaire   +2 more sources

Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas

Obstetrics and Gynecology, 2023
Oral gonadotropin-releasing hormone antagonists with low-dose add-back therapy or at submaximal suppression doses are effective in the treatment of leiomyoma symptoms while minimizing side effects.
M. Neblett, E. Stewart
semanticscholar   +1 more source

Lower odds of cardiac events for gonadotrophin‐releasing hormone antagonists versus agonists

BJU International, 2020
Induction of hypogonadism is standard-of-care for advanced prostate cancer. Gonadotropic releasing hormone (GnRH) agonists and antagonists lower testosterone with similar efficacy but may be associated with increased cardiovascular risk.
E. Cone, M. Marchese, S. Reese, Maxine Sun, J. Nabi, K. Kilbridge, Q. Trinh   +6 more
semanticscholar   +1 more source

The skeletal effects of gonadotropin-releasing hormone antagonists: a concise review.

Endocrine, Metabolic & Immune Disorders - Drug Targets, 2020
Prolonged treatment with gonadotropin-releasing hormone (GnRH) agonists is known to induce bone loss among prostate cancer patients. However, evidence on the skeletal effects of GnRH antagonists is relatively less well-known.
Nur-Vaizura Mohamad, I. Soelaiman, K. Chin   +2 more
semanticscholar   +1 more source